Zobrazeno 1 - 10
of 1 389
pro vyhledávání: '"locally advanced breast cancer"'
Publikováno v:
Breast Cancer: Targets and Therapy, Vol Volume 16, Pp 761-768 (2024)
Minghui Li,1,* Yuelin Liu,1,* Xu Han,1,* Tao Li,2 Zhizheng Zhang,1 Ningyi Xue,1 Mengdi Liang,1 Ge Ma,1 Tiansong Xia1 1Department of Breast Surgery, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, People’s
Externí odkaz:
https://doaj.org/article/6925d341bdbc4c3aa69e679e0c46e5ad
Autor:
Farhad Ghasemi, Muriel Brackstone
Publikováno v:
Current Oncology, Vol 31, Iss 10, Pp 6007-6016 (2024)
The utility of neoadjuvant chemotherapy is expanding in the treatment of breast cancer. Although individual trials have shown comparable survival between patients receiving neoadjuvant and adjuvant chemotherapy, large-scale data analyses for outcomes
Externí odkaz:
https://doaj.org/article/d077cdeeda2e4cb0b324700a150d6263
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 837-842 (2024)
Background: Due to its indolent biology and high estrogen receptor positivity of mucinous breast cancer, vast majority of locally advanced mucinous breast cancer (LABC) are treated with first-line endocrine therapy. Case Presentation: A 50-year-old w
Externí odkaz:
https://doaj.org/article/6070d88ab98748d6aba39af661c93a57
Autor:
Rexeena V. Bhargavan, Nisha Prasannan, K.M. Jagathnath Krishna, Paul Augustine, Kurian Cherian
Publikováno v:
South Asian Journal of Cancer, Vol 13, Iss 03, Pp 170-176 (2024)
Externí odkaz:
https://doaj.org/article/1583a52fe43c4eb88fc75d7a27412945
Publikováno v:
Mìžnarodnij Endokrinologìčnij Žurnal, Vol 20, Iss 4, Pp 233-237 (2024)
The authors have studied, analyzed, and summarized the data from publications of recent decades regarding the effect of vitamin D on the outcomes of breast cancer treatment, the place and role of its active form and metabolites at the stages of carci
Externí odkaz:
https://doaj.org/article/20b8a61ec5064773b864952da10429af
Autor:
Cheng-Yu Zeng, Yan-Yu Qiu, Jia-Yi Li, Jian-Hao Huang, Xue-Song Bai, Xian-Lin Han, Xiao-Dong He
Publikováno v:
World Journal of Surgical Oncology, Vol 22, Iss 1, Pp 1-9 (2024)
Abstract Background The purpose of this study was to compare safety and efficacy outcomes between immediate breast reconstruction (IBR) and mastectomy alone in locally advanced breast cancer patients. Methods We conducted a comprehensive literature s
Externí odkaz:
https://doaj.org/article/709e04aec2054ed68109a2b1e469c4f5
Publikováno v:
Journal of Nanobiotechnology, Vol 22, Iss 1, Pp 1-34 (2024)
Abstract Locally advanced breast cancer (LABC) is a heterogeneous group of breast cancer that accounts for 10–30% of breast cancer cases. Despite the ongoing development of current treatment methods, LABC remains a severe and complex public health
Externí odkaz:
https://doaj.org/article/9807b100f67a42e7b2a647c5080c14df
Publikováno v:
Frontiers in Surgery, Vol 11 (2024)
Locally advanced breast cancer (LABC) remains a significant clinical challenge, particularly in developing countries. While neoadjuvant systemic therapy (NST) has improved the pathological complete response (pCR) rates, particularly in HER2-positive
Externí odkaz:
https://doaj.org/article/0c92d8455b214a02971b172b7c5be410
Autor:
Letizia Cuniolo, Marco Gipponi, Federica Murelli, Francesca Depaoli, Chiara Cornacchia, Simonetta Franchelli, Marianna Pesce, Elena Ronda, Stefano Picardi, Raquel Diaz, Francesca Poggio, Daniele Friedman, Franco De Cian, Piero Fregatti
Publikováno v:
Current Oncology, Vol 31, Iss 5, Pp 2856-2866 (2024)
Locally advanced breast cancer (LABC) is a complex disease that requires a multidisciplinary approach. Neoadjuvant chemotherapy (NAC) is usually performed in order to achieve loco-regional radical resection; although its importance in the multidiscip
Externí odkaz:
https://doaj.org/article/73704bc0fb9649ce83be32abb56a0f0d
Autor:
Desak Gede Agung Suprabawati, Bernadeta Hernik Setiyandari, Dwi Hari Susilo, Bara Kharisma, Rizki Amalia
Publikováno v:
Biomolecular and Health Science Journal, Vol 7, Iss 1, Pp 1-4 (2024)
Introduction: Aromatase inhibitors are hormonal therapies used in menopausal breast cancer with positive progesterone receptors and/or estrogen receptors. A third-generation aromatase inhibitor is divided into two categories: reversible nonsteroids a
Externí odkaz:
https://doaj.org/article/fdefb2cb92004ebcb73643d131d5ee06